Barriers to Care in Patients With Rectal Bleeding in Nigeria
NCT ID: NCT02855385
Last Updated: 2016-08-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
134 participants
OBSERVATIONAL
2013-04-30
2014-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Community Based Screening for Colorectal Cancer in an Underserved High Risk Population in Nigeria
NCT03032874
Building Capacity for Screening & Early Diagnosis of Colorectal Cancer Through a Comprehensive Colonoscopy Training Program in Nigeria
NCT05686499
Colorectal Cancer Awareness, Research and Education and Screening - Rural Expansion, Access and Capacity for Health
NCT04464668
Identification of New Colorectal Cancer Genes
NCT00582335
Increasing Colorectal Cancer Screening in African Americans
NCT00893295
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
General practitioners in three cities will be contacted to assess their screening strategy for patients with rectal bleeding
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patient group
This are patients who have current or previous history of rectal bleeding
No interventions assigned to this group
General Practitioner group
This are General practitioner who are in public or private hospitals who treat patients with rectal bleeding
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Memorial Sloan Kettering Cancer Center
OTHER
University of Ilorin Teaching Hospital
OTHER
University College Hospital, Ibadan
OTHER
Obafemi Awolowo University Teaching Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Olusegun Alatise
Consultant Surgeon/Senior Lecturer
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ERC/2013/09/01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.